NICE guidance – updates

Keeping you up-to-date

Guidance by topic: the following guidance topics matching your health area preferences have been published or updated

• Acute coronary syndrome – rivaroxaban [ID532]                                                          
• Antenatal and postnatal mental health (update)                                                            
• Antenatal care                                                                                                                
• Arrythmias – ICDs & Heart failure – cardiac resynchronisation [ID481]                        
• Arthritis of the hip (end stage) – hip replacement (total) and resurfacing arthroplasty (Rev TA2, TA44) [ID540]   
• Asthma – diagnosis and monitoring                                                                               
• Atrial fibrillation (stroke prevention) – rivaroxaban                                                      
• Atrial fibrillation – dabigatran etexilate                                                                          
• BMI and waist circumference – black, Asian and minority ethnic groups                      
• Breast cancer (HER2 negative, oestrogen receptor positive, locally advanced or metastatic) – everolimus (with an aromatase inhibitor) [ID538]                                                                                        
• Colorectal cancer (metastatic) – regorafenib [ID593]                                                   
• EXOGEN ultrasound bone healing system for long bone fractures with non-union or delayed healing         
• Familial breast cancer                                                                                                    
• Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in early breast cancer management: MammaPrint, Oncotype DX, IHC4 and Mammostrat  
• Intrapartum care                                                                                                           
• Lung cancer (non-small-cell, anaplastic lymphoma kinase fusion gene, previously treated) – crizotinib [ID499]    
• Mega Soft Patient Return Electrode for use during monopolar electrosurgery             
• Multiple myeloma – bortezomib (induction therapy) [ID610]                                        
• Non Hodgkin’s lymphoma (relapsed refractory) – pixantrone monotherapy [ID414]    
• Prostate cancer (hormone relapsed, metastatic) – enzalutamide (after docetaxel)       
• Psoriatic arthritis (active, progressive) – ustekinumab [ID607]                                   
• Pulmonary embolism (acute treatment, VTE prevention) – rivaroxaban [ID569]          
• Pulmonary embolism and recurrent venous thromboembolism – rivaroxaban              
• Self-monitoring coagulometers (CoaguChek XS system, INRatio2 PT/INR monitor and ProTime Microcoagulation system), for self-testing or self-managing coagulation status in people for whom long-term vitamin K antagonist therapy is intended.                                                                                                       
• Systemic lupus erythematosus (autoantibody-positive) – belimumab [ID416]             
• Tuberculosis (update)                                                                                                   
• Ulcerative colitis                                                                                                            
• WatchBP Home A for opportunistically detecting atrial fibrillation during diagnosis and monitoring of hypertension